Nuveen’s BioNTech BNTX Stock Holding History

Nuveen’s Portfolio BNTX Stock Details BNTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$372K	Buy	+3,994	New	+$376K	﹤0.01%	3413
2023 Q2	–	Sell	-162,518	Closed	-$20.2M	–	3219
2023 Q1	$20.2M	Sell	162,518 -146,764	-47%	-$20.2M	0.01%	1038
2022 Q4	$46.5M	Buy	309,282 +100,887	+48%	+$15.5M	0.02%	565
2022 Q3	$28.1M	Buy	208,395 +55,925	+37%	+$8.55M	0.01%	801
2022 Q2	$22.7M	Sell	152,470 -37,530	-20%	-$5.73M	0.01%	961
2022 Q1	$32.4M	Buy	190,000 +182,634	+2,479%	+$30.7M	0.01%	878
2021 Q4	$1.9M	Sell	7,366 -180,709	-96%	-$49.5M	﹤0.01%	2587
2021 Q3	$51.3M	Buy	188,075 +183,376	+3,902%	+$58.3M	0.02%	676
2021 Q2	$1.05M	Sell	4,699 -98	-2%	-$18.5K	﹤0.01%	2987
2021 Q1	$524K	Buy	+4,797	New	+$509K	﹤0.01%	3090

Other funds holding BNTX

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return

Flossbach Von Storch Cologne, Germany $22.1B AUM 6.81% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return

BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return

LGM

Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return

GSK plc London $602M AUM

Nuveen's BNTX Position: Q2 2026 in Review

Nuveen opened a new position in BioNTech (BNTX) in Q2 2026: 3,994 shares worth $372K. The stake represents ﹤0.01% of the portfolio and ranks #3413 among its holdings. This is a return to the name: Nuveen previously reported a position in BNTX as recently as Q1 2023.

Nuveen first reported a position in BNTX in Q1 2021 and has held it in 10 quarters since. The position peaked at $51.3M in Q3 2021. 282 funds tracked by Wall St. Rank hold BNTX as of Q2 2026.

Nuveen held 3,994 shares of BioNTech worth $372K as of Q2 2026.
BioNTech was a new Nuveen position in Q2 2026.
BioNTech made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #3413 holding.
Nuveen first reported a position in BioNTech in Q1 2021 and has held it in 10 quarters since.
Nuveen's BioNTech position peaked at $51.3M in Q3 2021.
282 funds tracked by Wall St. Rank held BioNTech as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.